You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

M918T

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Respiratory Syncytial Virus Trial in Worldwide (mRNA-1345)

Not yet recruiting
  • Respiratory Syncytial Virus
  • mRNA-1345
  • Glendale, Arizona
  • +47 more
Sep 27, 2023

Hypertriglyceridemia Trial in Cork (Placebo, Candida cylindracea lipase (225,000 FIP lipase units per day), Candida cylindracea

Completed
  • Hypertriglyceridemia
  • Placebo
  • +3 more
  • Cork, Co. Cork, Ireland
    Atlantia Food Clinical Trials, Western Gateway Bldg, University
Mar 21, 2022

Elevated Triglycerides Trial in London, Toronto (GFA-918, Placebo)

Completed
  • Elevated Triglycerides
  • GFA-918
  • Placebo
  • London, Ontario, Canada
  • +1 more
Dec 21, 2021

Lung Cancer Stage IV, EGFR T790M Trial in Seoul (Lazertinib)

Not yet recruiting
  • Lung Cancer Stage IV
  • EGFR T790M
  • Seoul, MA, Korea, Republic of
    Samsung Medical Center
Jan 26, 2023

Cardiomyopathy Using Cardiac MRI (AID-MRI)

Not yet recruiting
  • Cardiomyopathies
    • Calgary, Alberta, Canada
    • +3 more
    Mar 30, 2023

    Healthy Trial in Nottingham (Ref (TF2), Evobrutinib MR-T1, Evobrutinib MR-T2)

    Recruiting
    • Healthy
    • Ref (TF2)
    • +8 more
    • Nottingham, United Kingdom
      Quotient Clinical Ltd
    Jul 11, 2022

    Oral Squamous Cell Carcinoma, Neck Dissection Trial (Elective neck dissection, Therapeutic neck dissection)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Neck Dissection
    • Elective neck dissection
    • Therapeutic neck dissection
    • (no location specified)
    Apr 10, 2023

    Diffuse Midline Glioma, H3 K27M-Mutant Trial in San Francisco (Cyclophosphamide, Fludarabine, Autologous Anti-H3.3K27M

    Not yet recruiting
    • Diffuse Midline Glioma, H3 K27M-Mutant
    • San Francisco, California
      University of California, San Francisco
    Aug 15, 2022

    Epilepsy, Epilepsies, Partial Trial in Calgary (Ibuprofen, Nifedipine, Placebo)

    Recruiting
    • Epilepsy
    • Epilepsies, Partial
    • Calgary, Alberta, Canada
    • +1 more
    Nov 15, 2022

    VitalThings Guardian Contactless Monitoring

    Not yet recruiting
    • Respiratory Depression
    • +2 more
    • Vitalthings Guardian M10 fixed and M10 mobile
    • (no location specified)
    Oct 13, 2023

    Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL) Trial (Fludarabine (30 mg/m^2), Cyclophosphamide (500 mg/m^2), CRG-022

    Not yet recruiting
    • Cancer
    • Relapsed/Refractory Large B-cell Lymphoma (LBCL)
    • Fludarabine (30 mg/m^2)
    • +2 more
    • (no location specified)
    Jul 25, 2023

    MT2017-45: CAR-T Cell Therapy for Heme Malignancies

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Large B-cell Lymphoma
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Nov 2, 2022

    Cancer Of Prostate Trial run by the National Cancer Institute (NCI) (M9241, Stereotactic Body Radiation Therapy (SBRT))

    Recruiting
    • Cancer Of Prostate
    • M9241
    • Stereotactic Body Radiation Therapy (SBRT)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Mogamulizumab, Brentuximab vedotin)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Mycosis Fungoides
    • (no location specified)
    Dec 7, 2022

    EGFR T790M, Osimertinib, NSCLC Trial in Beijing (Osimertinib)

    Recruiting
    • EGFR T790M
    • +3 more
    • Beijing, Beijing, China
      Junling Li
    Jul 21, 2022

    Elbow Fracture, Elbow Injury, Elbow Dislocation Trial in Canada, United States (Lactose Placebo, Ketotifen Fumarate 2mg,

    Recruiting
    • Elbow Fracture
    • +2 more
    • Lactose Placebo
    • +2 more
    • Baltimore, Maryland
    • +16 more
    Dec 8, 2022

    Diffuse Midline Glioma, H3 K27M-Mutant Trial (GD2 CAR T cells)

    Not yet recruiting
    • Diffuse Midline Glioma, H3 K27M-Mutant
    • GD2 CAR T cells
    • (no location specified)
    Sep 15, 2022

    PMCF Study for Peripheral Arteries Above the Knee (ATK)

    Recruiting
    • Peripheral Arterial Disease
    • +2 more
      • Klagenfurt am Wörthersee, Austria
        KABEG-Klinikum Klagenfurt am Wörthersee
      Jul 18, 2022

      COVID-19 Trial in Canada (Artesunate, Imatinib, Infliximab)

      Recruiting
      • COVID-19
      • Calgary, Alberta, Canada
      • +56 more
      Jan 12, 2023

      Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)

      Not yet recruiting
      • Bipolar Disorder
      • Calgary, Alberta, Canada
      • +7 more
      May 18, 2023

      Chronic Pain, Knee Pain Chronic, Post Operative Pain Trial in Toronto (Vitamin C, Placebo)

      Not yet recruiting
      • Chronic Pain
      • +2 more
      • Vitamin C
      • Placebo
      • Toronto, Ontario, Canada
      • +2 more
      Nov 7, 2023

      Hunter Syndrome Trial in Canada, France (Idursulfase-IT, Elaprase)

      Not yet recruiting
      • Hunter Syndrome
      • Calgary, Alberta, Canada
      • +3 more
      Sep 4, 2023

      Among Offspring of Women With Type 1 Diabetes

      Not yet recruiting
      • Neurocognitive Disorders
        • Calgary, Alberta, Canada
        • +1 more
        Mar 3, 2023

        Metastatic Lung Non-Small Cell Carcinoma, EGFR T790M Trial in Seoul (Lazertinib)

        Not yet recruiting
        • Metastatic Lung Non-Small Cell Carcinoma
        • EGFR T790M
        • Seoul, Korea, Republic of
          Samsung Medical Center
        May 18, 2022

        Critical Illness Trial in Canada (Albumin Fluid Resuscitation Optimization Intervention, Usual Practice)

        Completed
        • Critical Illness
        • Albumin Fluid Resuscitation Optimization Intervention
        • Usual Practice
        • Calgary, Alberta, Canada
        • +14 more
        Oct 31, 2022